Regulated CD18 expression in the haematopoietic gene therapy of leukocyte adhesion deficiency type I (LAD-I)

被引：0
|
作者：
Mesa-Nunez, C. [1 ,2 ,3 ]
Damian, C. [1 ,2 ,3 ]
Leon-Rico, D. [1 ,2 ,3 ]
Aldea, M. [1 ,2 ,3 ]
Thrasher, A. J. [4 ]
Bueren, J. A. [1 ,2 ,3 ]
Almarza, E. [1 ,2 ,3 ]
机构：
[1] Ctr Invest Energet Medioambientales & Tecnol CIEM, Div Haematopoiet Innovat Therapies, Madrid 28040, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28040, Spain
[3] Fdn Jimenez Diaz IIS FJD UAM, Inst Invest Sanitaria, Adv Therapies Unit, Madrid, Spain
[4] Univ Coll London ICH UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P014
引用
收藏
页码：A22 / A22
页数：1
相关论文
共 50 条
  • [31] Autologous Ex-Vivo Lentiviral Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results from an Ongoing Phase 1/2 Study
    Kohn, Donald B.
    Sevilla, Julian
    Rao, Gayatri
    Lopez, Maria Chitty
    Almarza, Elena
    Terrazas, Dayna
    Zubicaray, Josune
    Gonzalez-Vicent, Marta
    Chetty, Kritika
    O'Toole, Grainne
    Xu-Bayford, Jinhua
    Nicoletti, Eileen
    Fernandez, Augustine
    Kuo, Caroline Y.
    De Oliveira, Satiro N.
    Moore, Theodore B.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian J.
    Bueren, Juan A.
    Schwartz, Jonathan
    Booth, Claire
    MOLECULAR THERAPY, 2023, 31 (04) : 727 - 728
  • [32] Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
    Kohn, D. B.
    Sevilla, J.
    Rao, G.
    Chitty Lopez, M.
    Almarza, E.
    Terrazas, D.
    Zubicaray, J.
    Gonzalez-Vicent, M.
    Chetty, K.
    O'Toole, G.
    Xu-Bayford, J.
    Nicoletti, E.
    Fernandes, A.
    Kuo, C.
    de Oliveira, S.
    Moore, T. B.
    Choi, G.
    Zeini, M.
    Mesa-Nunez, C.
    Thrasher, A. J.
    Bueren, J.
    Schwartz, J.
    Booth, C.
    MOLECULAR THERAPY, 2022, 30 (04) : 550 - 550
  • [33] Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
    Booth, Claire
    Sevilla, Julian
    Rao, Gayatri R.
    Lopez, Maria Chitty
    Almarza, Elena
    Terrazas, Dayna
    Zubicaray, Josune
    Gonzalez Vicent, Marta
    Chetty, Kritika
    O'Toole, Grainne
    Xu-Bayford, Jinhua
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    de Oliveira, Satiro
    Moore, Theodore B.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian J.
    Bueren, Juan A.
    Schwartz, Jonathan D.
    Kohn, Donald B.
    BLOOD, 2022, 140 : 7774 - 7775
  • [34] A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Results from Phase 1
    Kohn, Donald B.
    Rao, Gayatri R.
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro N.
    Moore, Theodore B.
    Law, Kenneth M.
    Beard, Brian C.
    Sevilla, Julian
    Mesa-Nunez, Cristina
    Bueren, Juan A.
    Schwartz, Jonathan D.
    BLOOD, 2020, 136
  • [35] Reversion mutations in 3 patients with leukocyte adhesion deficiency Type I leading to CD18 expression on CD3+/CD8+/CD57+T cells.
    Uzel, G
    Rosenzweig, SD
    Shaw, JM
    Tng, E
    Horwitz, ME
    Linton, GF
    Anderson, SM
    Kirby, MR
    Gallin, JI
    Fleisher, TA
    Law, SKA
    Holland, SM
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S143 - S144
  • [36] Understanding the Role of LFA-1 in Leukocyte Adhesion Deficiency Type I (LAD I): Moving towards Inflammation?
    Fekadu, Julia
    Modlich, Ute
    Bader, Peter
    Bakhtiar, Shahrzad
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [37] LENTIVIRAL-MEDIATED EX-VIVO GENE THERAPY FOR PEDIATRIC PATIENTS WITH SEVERE LEUKOCYTE ADHESION DEFICIENCY-I (LAD-I): INTERIM RESULTS FROM AN ONGOING PHASE 1/2 STUDY
    Kohn, Donald
    Sevilla, Julian
    Rao, Gayatri
    Lopez, Maria Chitty
    Almarza, Elena
    Terrazas, Dayna
    Zubicaray, Josune
    Gonzalez-Vicent, Marta
    Chetty, Kritika
    O'Toole, Grainne
    Xu-Bayford, Jinhua
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro
    Moore, Theodore B.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian
    Bueren, Juan
    Schwartz, Jonathan
    Booth, Claire
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 61 - 62
  • [38] Neutrophil Function in a Leucocyte Adhesion Deficiency Type I (LAD I) Patient
    Perez, L.
    Regairaz, L.
    Bustamante, J.
    Garcia, M.
    Cabanillas, D.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S261 - S262
  • [39] Partial genomic structure of the bovine CD18 gene and the refinement of test for bovine leukocyte adhesion deficiency
    Kriegesmann, B
    Jansen, S
    Baumgartner, BG
    Brenig, B
    JOURNAL OF DAIRY SCIENCE, 1997, 80 (10) : 2547 - 2549
  • [40] CD11/CD18 POSITIVE T-CELL CLONE IN A PATIENT WITH SEVERE LEUKOCYTE ADHESION DEFICIENCY (LAD) - REVERSION OF A POINT MUTATION
    ZHU, Q
    HICKSTEIN, DD
    OCHS, HD
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A261 - A261
12345